DNDi's Model

The DNDi business model can be characterized by the following distinguishing traits:

1. A stepwise, integrated model of drug R&D

• with a primary R&D focus on the kinetoplastid diseases (HAT, VL, Chagas)
• with needs-driven R&D projects that can be sourced at any stage of the R&D pipeline

2. A virtual organisation, managing collaborative R&D projects
3. A needs-driven regulatory and access strategy
4. R&D networks that utilise and strengthen research capacities in disease-endemic countries
5. International advocacy to support DNDi’s R&D objectives and foster an improved global framework for essential health R&D